98 related articles for article (PubMed ID: 2738917)
1. Human D-Phe-Pro-Arg-CH2-alpha-thrombin crystallization and diffraction data.
Skrzypczak-Jankun E; Rydel TJ; Tulinsky A; Fenton JW; Mann KG
J Mol Biol; 1989 Apr; 206(4):755-7. PubMed ID: 2738917
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
3. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray diffraction analysis of gingipain R2 from Porphyromonas gingivalis in complex with H-D-Phe-Phe-Arg-chloromethylketone.
Banbula A; Potempa J; Travis J; Bode W; Medrano FJ
Protein Sci; 1998 May; 7(5):1259-61. PubMed ID: 9605333
[TBL] [Abstract][Full Text] [Related]
5. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
6. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.
Bode W; Mayr I; Baumann U; Huber R; Stone SR; Hofsteenge J
EMBO J; 1989 Nov; 8(11):3467-75. PubMed ID: 2583108
[TBL] [Abstract][Full Text] [Related]
7. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
8. Immobilization of the irreversible thrombin inhibitor D-Phe-Pro-Arg-chloromethylketone: a concept for hemocompatible surfaces?
Maitz MF; Sperling C; Werner C
J Biomed Mater Res A; 2010 Sep; 94(3):905-12. PubMed ID: 20730927
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin.
Carvalho Figueiredo A; Clement CC; Philipp M; Barbosa Pereira PJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):54-8. PubMed ID: 21206024
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary diffraction data of Escherichia coli ADP glucose pyrophosphorylase.
Mulichak AM; Skrzypczak-Jankun E; Rydel TJ; Tulinsky A; Preiss J
J Biol Chem; 1988 Nov; 263(33):17237-8. PubMed ID: 2846559
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray crystallographic analysis of alpha-amylase from Bacillus subtilis.
Chang C; Kim KK; Hwang KY; Choi MU; Suh SW
J Mol Biol; 1993 Jan; 229(1):235-8. PubMed ID: 8421303
[TBL] [Abstract][Full Text] [Related]
12. Peptide modified gold-coated polyurethanes as thrombin scavenging surfaces.
Sun X; Sheardown H; Tengvall P; Brash JL
J Biomed Mater Res; 2000 Jan; 49(1):66-78. PubMed ID: 10559748
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray analysis of human alpha-galactosidase A complex.
Murali R; Ioannou YA; Desnick RJ; Burnett RM
J Mol Biol; 1994 Jun; 239(4):578-80. PubMed ID: 8006970
[TBL] [Abstract][Full Text] [Related]
14. Isolation, crystallization and preliminary diffraction analyses of human pancreatic alpha-amylase.
Burk D; Wang Y; Dombroski D; Berghuis AM; Evans SV; Luo Y; Withers SG; Brayer GD
J Mol Biol; 1993 Apr; 230(3):1084-5. PubMed ID: 8478920
[TBL] [Abstract][Full Text] [Related]
15. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
16. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
17. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin.
Shin DH; Hwang KY; Kim KK; Lee HR; Lee CS; Chung CH; Suh SW
J Mol Biol; 1993 Feb; 229(4):1157-8. PubMed ID: 8445642
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and initial crystallographic results for pepstatin A inhibited bovine cathepsin D.
Bieber F; Brachvogel V; Arni R; Fusek M; Metcalf P
J Mol Biol; 1992 Oct; 227(4):1265-8. PubMed ID: 1433300
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary X-ray investigation of bovine liver mitochondrial aldehyde dehydrogenase.
Hurley TD; Weiner H
J Mol Biol; 1992 Oct; 227(4):1255-7. PubMed ID: 1433298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
